These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8066211)

  • 41. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
    Lee LJ; Damato AL; Viswanathan AN
    Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perineal template techniques for interstitial implantation of gynecological cancers using the Paris system of dosimetry.
    Leung S
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):769-74. PubMed ID: 2211225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A fast inverse treatment planning strategy facilitating optimized catheter selection in image-guided high-dose-rate interstitial gynecologic brachytherapy.
    Guthier CV; Damato AL; Hesser JW; Viswanathan AN; Cormack RA
    Med Phys; 2017 Dec; 44(12):6117-6127. PubMed ID: 28921538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
    Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
    Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and evaluation of an automatic interstitial catheter digitization tool for adaptive high-dose-rate brachytherapy.
    Dise J; Liang X; Scheuermann J; Anamalayil S; Mesina C; Lin LL; Teo BK
    Brachytherapy; 2015; 14(5):619-25. PubMed ID: 26073225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
    Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
    J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxicity associated with bowel or bladder puncture during gynecologic interstitial brachytherapy.
    Shah AP; Strauss JB; Gielda BT; Zusag TW
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):171-9. PubMed ID: 19695793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer.
    Beriwal S; Rwigema JC; Higgins E; Kim H; Houser C; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
    Brachytherapy; 2012; 11(3):176-80. PubMed ID: 21665553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
    Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
    Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-energy proton beam radiation therapy for gynecologic malignancies. Potential of proton beam as an alternative to brachytherapy.
    Arimoto T; Kitagawa T; Tsujii H; Ohhara K
    Cancer; 1991 Jul; 68(1):79-83. PubMed ID: 1904794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
    Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
    Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inversely and adaptively planned interstitial brachytherapy: A single implant approach.
    Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M
    Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interstitial therapy in gynecological cancer.
    Tak WK
    Gynecol Oncol; 1978 Oct; 6(5):429-37. PubMed ID: 738620
    [No Abstract]   [Full Text] [Related]  

  • 55. [Interstitial gamma therapy using automated remote-control positioning of radiation sources in the treatment of malignant vaginal and vulvar neoplasms].
    Nechushkin MI; Mar'ina LA; Uĭmanov VA; Riabtseva AM
    Vopr Onkol; 1998; 44(5):599-603. PubMed ID: 9884724
    [No Abstract]   [Full Text] [Related]  

  • 56. Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1335-43. PubMed ID: 19386443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation therapy for gynecologic malignancies.
    Bradley KA; Petereit DG
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):347-61. PubMed ID: 16730298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Radiotherapy of gynecologic cancers].
    Veraguth P; Alessandrini G; Berthier G; Merz WR
    Rev Med Suisse Romande; 1969 May; 89(5):429-47. PubMed ID: 5385887
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical implementation of 3D transvaginal ultrasound for intraoperative guidance of needle implant in template interstitial gynecologic high-dose-rate brachytherapy.
    Van Elburg D; Meyer T; Martell K; Quirk S; Banerjee R; Phan T; Fenster A; Roumeliotis M
    Brachytherapy; 2023; 22(6):790-799. PubMed ID: 37722991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.